• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人D-氨基酸氧化酶的特性分析

Characterization of human D-amino acid oxidase.

作者信息

Molla Gianluca, Sacchi Silvia, Bernasconi Mariagrazia, Pilone Mirella S, Fukui Kiyoshi, Polegioni Loredano

机构信息

Department of Biotechnology and Molecular Sciences, University of Insubria, Varese, Italy.

出版信息

FEBS Lett. 2006 Apr 17;580(9):2358-64. doi: 10.1016/j.febslet.2006.03.045.

DOI:10.1016/j.febslet.2006.03.045
PMID:16616139
Abstract

D-Amino acid oxidase (DAAO) has been proposed to be involved in the oxidation of D-serine, an allosteric activator of the NMDA-type glutamate receptor in the brain, and to be associated with the onset of schizophrenia. The recombinant human DAAO was expressed in Escherichia coli and was isolated as an active homodimeric flavoenzyme. It shows the properties of the dehydrogenase-oxidase class of flavoproteins, possesses a low kinetic efficiency, and follows a ternary complex (sequential) kinetic mechanism. In contrast to the other known DAAOs, the human enzyme is a stable homodimer even in the apoprotein form and weakly binds the cofactor in the free form.

摘要

D-氨基酸氧化酶(DAAO)被认为参与了D-丝氨酸的氧化过程,D-丝氨酸是大脑中N-甲基-D-天冬氨酸(NMDA)型谷氨酸受体的变构激活剂,且与精神分裂症的发病有关。重组人DAAO在大肠杆菌中表达,并作为一种活性同二聚体黄素酶被分离出来。它具有黄素蛋白脱氢酶-氧化酶类的特性,动力学效率较低,遵循三元复合物(有序)动力学机制。与其他已知的DAAO不同,人源酶即使以脱辅基蛋白形式存在也是稳定的同二聚体,并且以游离形式与辅因子的结合较弱。

相似文献

1
Characterization of human D-amino acid oxidase.人D-氨基酸氧化酶的特性分析
FEBS Lett. 2006 Apr 17;580(9):2358-64. doi: 10.1016/j.febslet.2006.03.045.
2
Is rat an appropriate animal model to study the involvement of D-serine catabolism in schizophrenia? Insights from characterization of D-amino acid oxidase.用大鼠作为研究精神分裂症中 D-丝氨酸代谢异常的动物模型是否合适?D-氨基酸氧化酶特性研究的启示。
FEBS J. 2011 Nov;278(22):4362-73. doi: 10.1111/j.1742-4658.2011.08354.x. Epub 2011 Oct 10.
3
Structure-function relationships in human D-amino acid oxidase.人源 D-氨基酸氧化酶的结构-功能关系。
Amino Acids. 2012 Nov;43(5):1833-50. doi: 10.1007/s00726-012-1345-4. Epub 2012 Aug 3.
4
Human D-amino acid oxidase: an update and review.人D-氨基酸氧化酶:最新进展与综述
Chem Rec. 2007;7(5):305-15. doi: 10.1002/tcr.20129.
5
The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia.利培酮对 D-氨基酸氧化酶活性的影响:一种治疗精神分裂症新作用机制的假说。
J Psychopharmacol. 2010 Jul;24(7):1055-67. doi: 10.1177/0269881109102644. Epub 2009 Mar 27.
6
Commentary: genome-based CNS drug discovery: D-amino acid oxidase (DAAO) as a novel target for antipsychotic medications: progress and challenges.述评:基于基因组的中枢神经系统药物发现:D-氨基酸氧化酶(DAAO)作为抗精神病药物的新靶点:进展与挑战
Biochem Pharmacol. 2009 Dec 1;78(11):1360-5. doi: 10.1016/j.bcp.2009.06.108. Epub 2009 Jul 8.
7
Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia.通过提高脑内甘氨酸和D-丝氨酸对NMDA受体进行变构调节:对精神分裂症的治疗潜力
Pharmacol Ther. 2008 Dec;120(3):317-32. doi: 10.1016/j.pharmthera.2008.08.004. Epub 2008 Aug 27.
8
D-amino acid oxidase inhibitors as a novel class of drugs for schizophrenia therapy.D-氨基酸氧化酶抑制剂作为一种新型抗精神分裂症药物。
Curr Pharm Des. 2013;19(14):2499-511. doi: 10.2174/1381612811319140002.
9
Comparative characterization of three D-aspartate oxidases and one D-amino acid oxidase from Caenorhabditis elegans.比较秀丽隐杆线虫中三种 D-天冬氨酸氧化酶和一种 D-氨基酸氧化酶的特性。
Chem Biodivers. 2010 Jun;7(6):1424-34. doi: 10.1002/cbdv.200900294.
10
Characterization of human DAAO variants potentially related to an increased risk of schizophrenia.可能与精神分裂症风险增加相关的人类D-氨基酸氧化酶变体的特征分析。
Biochim Biophys Acta. 2013 Mar;1832(3):400-10. doi: 10.1016/j.bbadis.2012.11.019. Epub 2012 Dec 5.

引用本文的文献

1
Modulating the serine metabolism in human differentiated astrocytes: an integrated multi omics approach.调节人分化星形胶质细胞中的丝氨酸代谢:一种综合多组学方法。
Front Cell Neurosci. 2025 Jul 21;19:1616911. doi: 10.3389/fncel.2025.1616911. eCollection 2025.
2
Prenatal Exposure to Lipopolysaccharide or Valproate Leads to Abnormal Accumulation of the NMDA Receptor Agonist D-Aspartate in the Adolescent Rat Brain.产前暴露于脂多糖或丙戊酸会导致青春期大鼠大脑中NMDA受体激动剂D-天冬氨酸异常积累。
J Neurochem. 2025 Jun;169(6):e70095. doi: 10.1111/jnc.70095.
3
Peptidoglycan-Targeted [F]3,3,3-Trifluoro-d-alanine Tracer for Imaging Bacterial Infection.
用于成像细菌感染的肽聚糖靶向[F]3,3,3-三氟-D-丙氨酸示踪剂
JACS Au. 2024 Feb 26;4(3):1039-1047. doi: 10.1021/jacsau.3c00776. eCollection 2024 Mar 25.
4
Amino Acid Chirality: Stereospecific Conversion and Physiological Implications.氨基酸手性:立体特异性转化及其生理意义
ACS Omega. 2024 Jan 26;9(5):5084-5099. doi: 10.1021/acsomega.3c08305. eCollection 2024 Feb 6.
5
Intestinal tryptophan metabolism in disease prevention and swine production.疾病预防与猪生产中的肠道色氨酸代谢
Anim Nutr. 2023 Aug 19;15:364-374. doi: 10.1016/j.aninu.2023.08.002. eCollection 2023 Dec.
6
d-Serine Increases Release of Acetylcholine in Rat Submandibular Glands.D-丝氨酸增加大鼠颌下腺中乙酰胆碱的释放。
Biology (Basel). 2023 Sep 11;12(9):1227. doi: 10.3390/biology12091227.
7
Tryptophan Metabolism 'Hub' Gene Expression Associates with Increased Inflammation and Severe Disease Outcomes in COVID-19 Infection and Inflammatory Bowel Disease.色氨酸代谢“枢纽”基因表达与 COVID-19 感染和炎症性肠病中的炎症增加和严重疾病结局相关。
Int J Mol Sci. 2022 Nov 26;23(23):14776. doi: 10.3390/ijms232314776.
8
Dysfunctional peroxisomal lipid metabolisms and their ocular manifestations.过氧化物酶体脂质代谢功能障碍及其眼部表现。
Front Cell Dev Biol. 2022 Sep 7;10:982564. doi: 10.3389/fcell.2022.982564. eCollection 2022.
9
Rational and Translational Implications of D-Amino Acids for Treatment-Resistant Schizophrenia: From Neurobiology to the Clinics.D-氨基酸治疗抵抗性精神分裂症的合理性和转化意义:从神经生物学到临床。
Biomolecules. 2022 Jun 29;12(7):909. doi: 10.3390/biom12070909.
10
Cadence discovery: study protocol for a dose-finding and mechanism of action clinical trial of sodium benzoate in people with treatment-refractory schizophrenia.节奏发现:苯甲酸钠治疗难治性精神分裂症的剂量探索和作用机制临床试验方案。
Trials. 2021 Dec 13;22(1):918. doi: 10.1186/s13063-021-05890-6.